A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.
Clinical trial NCT06133270 · COMPLETED
Trial details
- NCT number
- NCT06133270
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2024-07-04
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.